Brochure
23 Sep 2025
LP LDL - Innovative Patented Probiotic Strain for Cardiometabolic Health
PDF 1.5 MB
What distinguishes LPLDL ® from other probiotic strains is its remarkable efficacy in improving cardiometabolic biomarkers.
Elevated levels of cardiometabolic biomarkers are commonly tackled by approaches that come with multiple undesirable side effects, however LPLDL ® offers a scientifically backed and natural alternative to support cardiometabolic health and has seen no observed side effects in multiple human intervention studies.
Content provided by our supplier
ProBiotix Health
-
Country/Region:United Kingdom
-
On CPHI since:2025
-
Certificates:3
-
Employees:1 - 24
Company types
Primary activities
Other Content from ProBiotix Health (3)
-
Brochure LP LDL Product Solution - For Menopause Health
Discover YourBiotixMH, a ready-to-market menopause formulation designed to go beyond symptom relief. Explore the science-backed ingredients supporting cardio... -
Brochure LPLDL Product Solution - For Menopause
Discover YourBiotixMH, a ready-to-market menopause formulation designed to go beyond symptom relief. Explore the science-backed ingredients supporting cardiovascular, bone and hormonal health during and after menopause, including the clinically validated probiotic LPLDL®. -
Brochure ProBiotix Health Products Brochure - YourBiotix LP LDL
Elevate your product range with patented and scientifically validated probiotic strain LPLDL® in finished formulation formats available for private label.
Each formulation utilises specialised active ingredients for a comprehensive, multi-targeted approach. Supporting key areas including Cholesterol, Hypertension, and Vascular Health with assurance, safety and scientific validation.